Eyeworld

52 | EYEWORLD | APRIL 2023 ATARACT C I t's that time of year again as we lead up to the ASCRS Annual Meeting in San Diego, California. As the world around us inches closer to "normality," we'll have the opportunity to learn from each other, network with peers and industry, and catch up with old friends (and hopefully make some new ones). In anticipation of this fun and educational event, this issue of EyeWorld previews a few of the many valuable offerings available at the upcoming meeting on May 5–8. In this issue, you can read more on: • The views of Edward Holland, MD, on his experience as Program Chair of the ASCRS Annual Meeting • The thoughts of Doug Rhee, MD, about his term as ASCRS President • What's in store at ASCRS Subspecialty Day • Who will be honored with the Humanitari- an and Educator Awards • Who will deliver the Binkhorst, Lindstrom, and Innovator's Lectures In addition, this issue of EyeWorld tackles several challenges commonly associated with cataract surgery. Kevin M. Miller, MD, and Richard Tipperman, MD, share insights on postoperative issues that we might consider small but that our patients may perceive to be quite problematic. They'll discuss strategies to preemptively set patient expectations with respect to postoperative refractive error, resid- ual astigmatism, duration of visual recovery, cosmesis of IOL reflections, and ptosis. Postop- erative management of these conditions is also addressed, along with cystoid macular edema, dry eye syndrome, and corneal neuralgia. While these issues are challenging when they surround cataract surgery with conven- tional monofocal IOLs, several of them are significantly magnified in the setting of ad- vanced-technology IOL (ATIOL) use. As our IOL-based options for astigmatism and presby- opia correction increase, it becomes even more critical that we understand how to approach IOL selection and shepherd our patients through the process of adaptation. Kamran Riaz, MD, Linda Tsai, MD, and Li Wang, MD, PhD, discuss their approaches to optimizing the choice of IOL calculation formulas for use with ATIOLs. In addition to reviewing which formulas perform best in these eyes, they offer insights into how patients adapt to their new vision, red flags that may highlight patients less suited to ATIOLs, and strategies for managing unhappy patients post-implantation. Finally, I'm excited to hear from Rosa Braga-Mele, MD, and Brenton Finklea, MD, on a topic that I encounter on multiple occasions every week: patients' perceptions of cataract surgery in their fellow eye that differ from the experience they had with their first eye. We're all used to hearing comments such as "I don't remember this on my first eye" or "Did this surgery take longer than my other eye?" While we may become a little jaded in our approach to this "Groundhog Day" conversation, in reality it can be a significant source of patient unease. In addition to highlighting the specific areas where patients may perceive these differences, Drs. Braga-Mele and Finklea offer advice on how to counsel them beforehand to raise their aware- ness and address their concerns afterward to reduce their anxiety. We hope you enjoy this issue of EyeWorld and look forward to seeing you in San Diego at the 2023 ASCRS Annual Meeting. by Mitchell Weikert, MD Cataract Editor Tackling challenges commonly associated with cataract surgery As the world around us inches closer to "normality," we'll have the opportunity to learn from each other, network with peers and industry, and catch up with old friends.

• Blank Page
• Blank Page (1)